U.S. imposes fresh Iran-related sanctions targeting individual, entity

WASHINGTON (Reuters) - The United States on Thursday imposed fresh Iran-related sanctions, blacklisting an entity and an individual as Washington continues to ramp up pressure on Tehran during U.S. President Donald Trump's final months in office. The U.S.

Reuters December 04, 2020 02:05:34 IST
U.S. imposes fresh Iran-related sanctions targeting individual, entity

US imposes fresh Iranrelated sanctions targeting individual entity

WASHINGTON (Reuters) - The United States on Thursday imposed fresh Iran-related sanctions, blacklisting an entity and an individual as Washington continues to ramp up pressure on Tehran during U.S. President Donald Trump's final months in office.

The U.S. Treasury Department in a statement said that it had slapped sanctions on Shahid Meisami Group and its director, accusing the entity of being involved in Iran's chemical weapons research and linked to the Iranian Organization of Defensive Innovation and Research, blacklisted by Washington and formerly headed by the Islamic Republic's top nuclear scientist killed last week.

The move comes days after the killing of Mohsen Fakhrizadeh. Iran's supreme leader promised on Saturday to retaliate for the killing, raising the threat of a new confrontation with the West and Israel in the remaining weeks of Trump's presidency.

"Iran’s development of weapons of mass destruction is a threat to the security of its neighbors and the world," Treasury Secretary Steven Mnuchin said in the statement.

"The United States will continue to counter any efforts by the Iranian regime to develop chemical weapons that may be used by the regime or its proxy groups to advance their malign agenda," he added.

Thursday's action freezes any U.S. assets of those blacklisted, generally bars Americans from dealing with them and denies them access to the U.S. financial system.

"The United States is concerned about the regime’s true intent with regard to the testing and production of these so-called chemical incapacitation agents, which could be used either to further oppress Iranian citizens or for offensive purposes," U.S. Secretary of State Mike Pompeo said in a separate statement.

U.S. Special Envoy for Iran Elliott Abrams last week said the Trump administration would continue to tighten sanctions on Iran during its final months in office, with sanctions related to arms, weapons of mass destruction and human rights expected through December and January.

Tensions between Washington and Tehran have risen since Trump abandoned Obama's 2015 Iran nuclear deal, and restored harsh economic sanctions to pressure Tehran to negotiate deeper curbs on its nuclear program, ballistic missile development and support for regional proxy forces.

President-elect Joe Biden, set to take office on Jan. 20, has said he will return the United States to the Obama-era deal if Iran resumes compliance.

(Reporting by Daphne Psaledakis and Susan Heavey, Editing by Rosalba O'Brien, Jonathan Oatis and Diane Craft)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Republican-led Senate defies Trump, overrides defense bill veto
World

Republican-led Senate defies Trump, overrides defense bill veto

By David Morgan and Susan Heavey WASHINGTON (Reuters) - President Donald Trump's fellow Republicans in the U.S. Senate on Friday overrode his veto for the first time in his nearly four years in office, pushing through a bill on defense spending against his strong objections 20 days before he leaves office. Meeting in a rare New Year's Day session, the Senate secured the two-thirds majority needed to override the veto with bipartisan support two days before a new Congress will be sworn in on Sunday.

BioNTech founders warn of vaccine supply gaps - Spiegel
World

BioNTech founders warn of vaccine supply gaps - Spiegel

By Douglas Busvine BERLIN (Reuters) - BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps in supply until other vaccines were rolled out.

Volatile markets end 2020 strong with vaccines, stimulus in sight
Business

Volatile markets end 2020 strong with vaccines, stimulus in sight

By Naveen Thukral and Gavin Maguire SINGAPORE (Reuters) -Global commodity markets ended 2020 on a strong note, with recovering demand and widespread stimulus packages buoying prices after a roller coaster ride caused by the global coronavirus pandemic.